Clinical Trial Update: Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating ketamine infusion vs traditional anti-epileptic agents in refractory status epilepticus was withdrawn from phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Status Epilepticus

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Refractory Epilepsy | Phase 2, Phase 3 | Status: WITHDRAWN